COVID-19 vaccines
British drugs group AstraZeneca and the University of Oxford have achieved a "winning formula" for their Covid-19 vaccine, according to the company's chief executive Pascal Soriot. The vaccine, currently being evaluated by Britain's independent medicines regulator, provides 100 percent protection against severe Covid disease
Vaccines
In a year marked by the COVID-19 pandemic, the winter holidays have brought a season of hope with the emergence of two COVID-19 vaccines. The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to vaccines from Pfizer/BioNTech and Moderna, enabling distribution to high-risk groups. These
Vaccines
Mentor Capital, a company known for financially supporting leading-edge immunotherapies in the fight against cancer, has expanded its portfolio to include vaccine manufacturers and associated medical companies involved in the fight against SARS-CoV-2. The company's initial investments are in Pfizer, Moderna, BioNTech, and AstraZeneca, with a focus on
Vaccines
The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) has recommended emergency use approval for Pfizer/BioNTech's COVID-19 vaccine, paving the way for its immunization in the US. This comes after a 90-year-old British woman became the first person outside of a trial setting to
Vaccines
The US government has declined Pfizer's offers for additional batches of its COVID-19 vaccine, citing a bet on multiple vaccine options. Pfizer's board member and former FDA commissioner, Dr. Scott Gottlieb, stated that the company may not be able to offer more shots to the nation
Vaccines
Facebook announced a new policy to remove posts sharing false claims about COVID-19 vaccines from its platform and Instagram, in an effort to combat the spread of misinformation about the virus. The move comes as two leading vaccine candidates from Pfizer and Moderna await approval for emergency use authorization from
Vaccines
Supermarket pharmacy staff and food industry workers will be among the first groups in the nation to receive COVID-19 vaccines, following health care personnel and long-term care facility residents in Phase 1a of U.S. coronavirus vaccination allocation. The Centers for Disease Control and Prevention's (CDC) Advisory Committee
Pfizer Inc.
Monday's price swings in shares of travel and entertainment companies showed traders' optimism about a COVID-19 vaccine, but a deeper dive into real estate investment trusts (REITs) reveals a potential opportunity for investors. With many Americans likely to return to their offices and workplaces after the pandemic,
COVID-19 vaccines
The announcement of interim results of Pfizer's new coronavirus vaccine sparked tears of joy and excitement among employees, with the company's chief scientific officer, Mikael Dolsten, describing the moment as "historic". According to Dolsten, preliminary analysis has found the vaccine to be more than
Pfizer Inc.
Pharmaceutical firm Pfizer has announced its COVID-19 vaccine, developed in partnership with BioNTech, has shown more than 90% effectiveness in preventing people from developing the disease. The announcement comes after an interim analysis of data from a trial involving 43,500 people in six countries, with no safety concerns raised.
COVID-19 vaccines
Pfizer's experimental coronavirus vaccine has succeeded in the final stage of clinical trials, with an impressive 90% efficacy in preventing COVID-19, according to the latest announcement. This breakthrough has significant implications for the global fight against the pandemic, as it marks a crucial milestone in the development of
United States. Securities and Exchange Commission
Amgen Inc. has made a significant filing with the U.S. Securities and Exchange Commission (SEC), highlighting the company's commitment to transparency and compliance. The filing, which was posted on May 7, 2020, showcases Amgen's dedication to providing stakeholders with critical information about the company'
